Judge overturns Vioxx award vs Merck: WSJ
Posted on: Wednesday, 30 August 2006, 12:38 CDT
NEW YORK (Reuters) - A federal judge overturned a $50 million award handed down by jury against Merck & Co. earlier this month in a case of a former FBI agent who had blamed the withdrawn painkiller Vioxx for his heart attack, the Wall Street Journal reported on its web site on Wednesday.
Merck did not immediately return phone calls seeking comment.
A New Orleans jury in the federal trial had found that Merck knowingly misrepresented or failed to disclose a material fact regarding Vioxx safety to the plaintiff's physician.
The jury on August 17 awarded 62-year-old Gerald Barnett $50 million in compensatory damages and another $1 million in punitive damages.
Merck, which pulled Vioxx from the market in September of 2004 after a study found the drug doubled the risk of heart attack and stroke in long-term users, is facing more than 14,200 Vioxx product liability lawsuits.
Source: REUTERS
Related Articles
- Vioxx Trial Jury, Plaintiff Share Traits
- Vioxx Trial Jury Hears Closing Arguments
- No verdict in Texas Vioxx case; jury back Friday
- Vioxx trial jury awards $9 mln in punitive damages
- Merck Shares Jump As Jury Rules Out Liability for Vioxx
- Despite Actions on Vioxx, Merck Ekes Out Profit Gain MARKETPLACE By Bloomberg
- Merck Asks for Mistrial in Vioxx Case
- Vioxx Trial Seen As Crucial for Merck Jury Selection Begins in Atlantic City
- No Vioxx Verdict; Jury Seeks Data
- Vioxx Trial Jury Selection Expected to Start Today
 |
 |
User Comments (0)
RSS Feeds